← Back to Search

Coffee for Post-Operative Gastrointestinal Recovery

N/A
Waitlist Available
Led By Paul Karanicolas, MD PhD
Research Sponsored by Sunnybrook Health Sciences Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patient is scheduled to remain in hospital for at least one night, post-operatively
Age ≥ 18 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial is testing whether coffee can help reduce the time it takes for people to recover from surgery, without increasing complications or adverse events.

Who is the study for?
This trial is for adults over 18 who are having elective abdominal surgery and will stay in the hospital at least one night after. It's not for those with a known intolerance to coffee or caffeine, or unwilling to pause their current caffeine intake.Check my eligibility
What is being tested?
The study tests if drinking coffee, decaffeinated coffee, or warm water three times daily can help recover gastrointestinal function after abdominal surgery. Participants are randomly assigned to one of these drinks under the IMPACTS program.See study design
What are the potential side effects?
Since this trial involves common beverages like coffee and water, side effects may be minimal but could include typical reactions to caffeine such as jitteriness, increased heart rate, upset stomach, or trouble sleeping.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I will stay in the hospital for at least one night after surgery.
Select...
I am 18 years old or older.
Select...
I am scheduled for elective surgery in my abdomen.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Ability to collect complete data for patient-reported outcomes
Ability to deliver intervention patient is randomized to receive
Ability to link data from patient-reported outcome measures with Institute for Clinical/Evaluative Sciences and National Surgical Quality Improvement Program datasets
+2 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: CoffeeExperimental Treatment1 Intervention
Caffeinated coffee beverage
Group II: Decaffeinated coffeeActive Control1 Intervention
Decaffeinated coffee beverage
Group III: Warm waterPlacebo Group1 Intervention
Warm water beverage

Find a Location

Who is running the clinical trial?

Sunnybrook Health Sciences CentreLead Sponsor
656 Previous Clinical Trials
1,550,448 Total Patients Enrolled
Paul Karanicolas, MD PhDPrincipal InvestigatorSunnybrook Health Sciences Centre
5 Previous Clinical Trials
4,121 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~50 spots leftby Apr 2025